A clinical trial using stem cell transplants aims to grow a new immune system for people with untreated Crohn's disease. This innovative approach may help reduce gut inflammation and improve quality of life for patients suffering from the condition.
The largest randomized trial on genetic screening before embryo transfer found no difference in live birth rates between groups with and without the procedure. However, there was a lower miscarriage rate and fewer embryo transfers in the group that received genetic screening.
SourceEuropean Society of Human Reproduction and Embryology·JournalHuman Reproduction·DateAug 5, 2018